Both IOP and medication use were reduced and glaucoma did not progress in the majority of patients in a study looking at 5-year visual field and OCT outcomes after iStent implantation in a real-world clinical setting.
“The iStent was able to stabilize visual field and OCT outcomes while preserving conjunctiva. This study can assist future identification of risk factors for progression,” Richard A. Lehrer, MD, said during the virtual American Society of Cataract and Refractive Surgery meeting.
Lehrer and colleagues conducted a single-surgeon retrospective case series of 220 eyes
Uncategorized